Last updated 2026-06-18
- Raised $1.3M funding round, Nov 2022
- Raised $61k grant, Aug 2018
- Raised $450k funding round, Apr 2015
Total raised
$1.8M
Last: 2024-07
Stage
Seed
Founded
2013
Headcount
2
HQ
Israel
Sector
Health Tech & Life Sciences
About
S.T. Stent develops a composite, removable sinus stent designed to be placed in the ethmoid sinus following functional endoscopic sinus surgery to keep the cavity open for up to 28 days. The stent improves patient outcomes and reduces the probability of revision surgeries. The S.T. Stent adapts to the patients anatomy and does not irritate the tissue or migrate. It provides strong, stable support for the sinus walls and is made from biocompatible materials. The stent can be easily removed at any time in a minimally invasive procedure performed in the doctors office without the need for anesthesia. In 2018 the company was awarded FDA clearance for its sinus stent. S.T. Stent is part of the Trendlines Medical portfolio.
Funding history · 4 rounds · $1.8M total
2024-07
Undisclosed
2022-11
2018-08
Grant
$61K
2015-04
Q&A
- What is S.T. Stent's primary product?
- S.T. Stent develops a composite, removable sinus stent designed for placement in the ethmoid sinus after functional endoscopic sinus surgery. It aims to keep the cavity open for up to 28 days, improve patient outcomes, and reduce the likelihood of revision surgeries.
- When was S.T. Stent founded?
- S.T. Stent was founded in November 2013.
- How many employees does S.T. Stent currently have?
- S.T. Stent has 1-10 employees.
- What is the total amount of funding S.T. Stent has raised to date?
- S.T. Stent has raised a total of $1,761,000.
- When did S.T. Stent receive its most recent funding?
- S.T. Stent received its most recent funding in July 2024, with Katao Venture Partners as a lead investor.
- When did S.T. Stent receive FDA clearance for its sinus stent?
- S.T. Stent was awarded FDA clearance for its sinus stent in 2018.
- Who are the lead investors in S.T. Stent's November 2022 funding round?
- In November 2022, S.T. Stent raised funding from ExitValley and The Trendlines Group.
- What is S.T. Stent's primary sector?
- S.T. Stent's primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
medical-devicesinfectionsurgeryminimally-invasivestentallergychronic-diseaserespiratorymedical-productsdoctorshealthcare-providers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ststent.com |
|---|---|
| linkedin.com/company/5103405 |
Identifiers & details
| Founded | 2013-11 |
|---|---|
| Employees (exact) | 2 |
Radar intelligence
Web history (Wayback)
| Domain | ststent.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|